Chemical warfare antidote grant awarded

Published: June 25, 2008 at 6:02 PM

SAN ANTONIO, June 25 (UPI) -- The U.S. Army Space and Missile Defense Command has awarded a grant to the Southwest Research Institute for the development of a chemical warfare antidote.

San Antonio-based SwRI was awarded a $1.3 million grant for the development of a nerve agent antidote. Officials say soldiers are at risk of facing potential chemical warfare that attacks the body's central nervous system. With the grant money, SwRI says it will develop an injection-administered antidote.

SwRI's study is testing whether their antidote, MMB4, reverses the symptoms caused by a chemical warfare agent.

"The goal of this study is to develop an operationally stable formulation of MMB4 that is able to be absorbed quickly by the body, that will not hinder atropine, which is used in combination to effectively treat the effects of a chemical nerve agent," Joe McDonough, SwRI's Chemistry and Chemical Engineering Division principal investigator and manager of the Synthesis and Drug Delivery Section, said in a statement.

© 2008 United Press International, Inc. All Rights Reserved.
Order reprints


Drug may help restore damaged nerves (5 min)
Crosswinds builder caught in crossfire (10 min)
Namath dog famous -- and dangerous (32 min)
Doctors review hemicorporectomy procedures (46 min)
Markets put on early charge Monday (59 min)
Final STS-129 spacewalk under way
Better TB, malaria and AIDS tests urged
fark
Not news: Transit police officer forces passenger's head into a reinforced glass window. News: Window...
The coolest CG portraits you'll see today
Authorities decry assault on 12-year-old California boy as a result of "Kick A Ginger Day" internet...
Vatican hosts conference on extrasolar life, highlights need for that whole warp-drive thing
He brings a shotgun, you bring a bagel cart. That's the Orlando way
CDC Releases H1N1.6 Service Pack 2 (NSFWish ads)